Combination therapy comprising an ACC inhibitor
US11963961B2 · kind B2 · utility
0Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2021 |
| Grant date | Apr 23, 2024 |
| Priority date | — |
| Expiry date | Dec 27, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods and compositions for treating, stabilizing or lessening the severity or progression of a non-alcoholic fatty liver disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.